封面
市場調查報告書
商品編碼
1373848

全球避孕藥具和避孕器市場(2023-2030):規模、佔有率、成長分析和類型預測(口服避孕藥(避孕藥)/子宮內避孕器)

Global Contraceptives Market Size, Share, Growth Analysis, By Type(oral contraceptives (birth control pills), intrauterine devices (IUDs)) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球避孕藥和避孕器市場規模將從 2021 年的 232 億美元成長到 2022 年的 282.2 億美元,預測期內年複合成長率為 7.4%,到 2030 年將成長到 499.6 億美元。

全球避孕藥和避孕器市場正在經歷顯著成長,並受到多種因素的推動。計劃生育意識的提高、性行為感染(STI)盛行率的上升以及對有效避孕方法的需求不斷增加是推動市場成長的主要因素。此外,避孕技術的進步,例如長效可逆避孕藥具和避孕器(LARC)的開發以及多種避孕選擇的出現,也推動了市場的擴張。此外,旨在促進計劃生育和生殖健康的政府配合措施和計劃也為市場創造了有利的環境。

然而,社會恥辱、文化障礙以及某些地區獲得避孕器的機會有限等挑戰正在抑制因素市場成長。

本報告調查了全球避孕藥和避孕器市場,並提供了市場概況、影響市場的各種因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測以及各個細分市場和地區。編制了單獨的細分、競爭形勢、主要企業簡介等。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
    • 市場概況
    • 市場規模
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 關鍵市場洞察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • 啟動分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 重點投資分析
    • 關鍵成功因素
    • 競爭程度
    • 市場動態及展望
      • 市場動態
        • 促進因素
        • 機會
        • 抑制因素
        • 任務
    • 法規狀況
    • 波特的分析
    • Skyquest 對未來顛覆的獨家見解
  • 全球避孕藥和避孕器市場:按類型
    • 市場概況
    • 口服避孕藥(避孕藥)
    • 子宮內避孕器 (IUD)
    • 保險套
    • 避孕貼片
    • 注射避孕藥
    • 更多的
  • 全球避孕藥和避孕器市場:按地區
    • 市場概況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場地位
    • 主要企業的招募策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率
  • 主要企業簡介
    • Pfizer Inc.
    • Bayer AG
    • Merck & Co., Inc.
    • Johnson & Johnson Services, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Allergan plc
    • Reckitt Benckiser Group plc
    • Church & Dwight Co., Inc.
    • Mankind Pharma Ltd.
    • CooperSurgical, Inc.
    • Medisafe Distribution Inc
    • HLL Lifecare Limited
    • Mayer Laboratories, Inc.
    • Lupin Limited
    • Okamoto Industries, Inc
    • Actavis, Inc.
    • Ansell Limited
    • Cipla Limited
    • anssen Pharmaceuticals, Inc.
簡介目錄
Product Code: SQMIG35I2174

Global Contraceptives Market size was valued at USD 23.20 billion in 2021 and is poised to grow from USD 28.22 billion in 2022 to USD 49.96 billion by 2030, growing at a CAGR of 7.4% in the forecast period (2023-2030).

The global contraceptives market is witnessing significant growth and is driven by several factors. Increasing awareness about family planning, rising prevalence of sexually transmitted infections (STIs), and the growing demand for effective contraceptive methods are key factors contributing to market growth. Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) and the availability of a wide range of contraceptive options, are further fueling market expansion. Moreover, government initiatives and programs aimed at promoting family planning and reproductive health are creating a favorable environment for the market. However, challenges such as social stigma, cultural barriers, and limited access to contraceptives in certain regions pose restraints to market growth. Nonetheless, the increasing emphasis on women's health and the rising acceptance of contraception as a means of empowerment are expected to drive the growth of the global contraceptives market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptives Market Segmental Analysis

The global contraceptives market is segmented by type, application, and region. Based on type, the market can be segmented into oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptives Market Dynamics

Drivers of the Global Contraceptives Market

Increasing Awareness And Acceptance Of Family Planning And Reproductive Health

One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

Restraints in the Global Contraceptives Market

Cultural And Religious Barriers That Limit The Use And Acceptance Of Contraceptives

A major restraint in the global contraceptives market is the cultural and religious barriers that limit the use and acceptance of contraceptives in certain regions. In some societies, there are cultural or religious beliefs that discourage or restrict the use of contraceptives, leading to lower adoption rates. Moreover, inadequate access to contraceptives, particularly in rural and remote areas, can also act as a restraint. Limited availability, affordability, and lack of proper distribution channels can hinder the widespread use of contraceptives, especially in developing countries. Overcoming these cultural and logistical challenges is crucial for the market's further growth and ensuring universal access to effective contraception methods.

Market Trends of the Global Contraceptives Key

One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Contraceptives Market by Type
    • Market Overview
    • oral contraceptives (birth control pills)
    • intrauterine devices (IUDs)
    • condoms
    • contraceptive patches
    • injectable contraceptives
    • and more
  • Global Contraceptives Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson Services, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Church & Dwight Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CooperSurgical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • HLL Lifecare Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mayer Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lupin Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Okamoto Industries, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Actavis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ansell Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • anssen Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments